Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: Safety and immunogenicity in 12- to 24- and 2- to 4-month-old children-Reference-Cited by-同舟云学术

Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: Safety and immunogenicity in 12- to 24- and 2- to 4-month-old children

Published:1992-05 Issue:5 Volume:120 Page:680-685
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Podda Audino,De Luca Erminia Carapella,Titone Lucina,Casadei Anna Maria,Cascio Antonio,Peppoloni Samuele,Volpini Gianfranco,Marsili Ilio,Nencioni Luciano,Rappuoli Rino

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference20 articles.

1. Modern vaccines: Haemophilus influenzae infections and whooping cough;Moxon;Lancet,1990

2. Report of the Task Force on Pertussis and Pertussis Immunization;Cherry;Pediatrics,1988

3. Pertussis immunization and serious acute neurological illness in children;Miller;BMJ,1981

4. Pertussis vaccine encephalopathy: it is time to recognize it as the myth that it is;Cherry;JAMA,1990

5. Pertussis: epidemiology and control;Muller;Bull World Health Organ,1986

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two centuries of vaccination: historical and conceptual approach and future perspectives;Frontiers in Public Health;2024-01-09

2. The History of Pertussis Toxin;Toxins;2021-09-05

3. Long-lived immunity to genetically detoxified pertussis vaccines;EClinicalMedicine;2021-07

4. Secondary hemophagocytic lymphohistiocytosis in vector borne diseases: a systematic review;Gazzetta Medica Italiana Archivio per le Scienze Mediche;2018-10

5. Toxin-Based Mucosal Adjuvants;Immunopotentiators in Modern Vaccines;2017